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Abstract
Background Increased left ventricular mass (LVM) is an im-
portant risk marker of uremic cardiovascular disease.
Calculation of LVM by echocardiography (Echo) relies on
geometric assumptions and in adults on hemodialysis overes-
timates LVM compared to cardiac magnetic resonance
(CMR). We compare both techniques in children with chronic
kidney disease (CKD).
Methods Concurrent Echo and CMR was performed in
25 children with CKD (14 after kidney transplantation)
aged 8–17 years.
Results Compared to normal children, CMR-LVM was in-
creased (standard deviation score (SDS) 0.39±0.8 (p=
0.03)), stroke volume and cardiac output decreased (SDS
−1.76±1.1, p=0.002 and −1.11±2.0, p=0.001). CMR-LVM
index but not Echo-LVMI correlated to future glomerular
filtration rate (GFR) decline (r=−0.52, p=0.01). Mean
Echo-LVM was higher than CMR-LVM (117±40 vs. 89±
29 g, p<0.0001), with wide limits of agreement (−6.2 to
62.8 g). The Echo-CMR LVM difference increased with
higher Echo-LVMI (r=0.77, p<0.0001). Agreement of clas-
sifying left ventricular hypertrophy was poor with Cohen’s
kappa of 0.08. Mean Echo and CMR-ejection fraction differed
by 1.42 % with wide limits of agreement (−12.6 to 15.4 %).
Conclusions Echo overestimates LVM compared to CMR,
especially at higher LVM. Despite this, CMR confirms in-
creased LVM in children with CKD. Only CMR-LVMI but
not Echo-LVMI correlated to future GFR decline.
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Introduction
Cardiovascular mortality is the leading cause of death in adult
patients with chronic kidney disease and end-stage renal fail-
ure. Left ventricular mass (LVM) is an established risk marker
for prediction of mortality. Children with chronic kidney dis-
ease (CKD) also show features of beginning cardiovascular
disease such as left ventricular hypertrophy (LVH) [1, 2], al-
terations of systolic [3] and diastolic function [4, 5], increased
intima media thickness [6, 7], and stiffening of the aorta and
peripheral vessels [8], even though other risk factors such as
diabetes or smoking are normally absent. Despite the very low
cardiovascular mortality in this age group, early detection of
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cardiovascular abnormalities is still important in evaluating
the risk of and potentially prevent future cardiovascular
disease.
Echocardiography (Echo) offers a well-established and
non-invasive technique for cardiac examination. LVM can
be estimated by the American Society of Echocardiography
(ASE) formula, which is validated by autopsy in adults [9].
LVM-index (LVMI) to body height to the power of 2.7 is
preferred over normalization to body surface area (BSA) as
the latter underestimates LVH in overweight patients [10].
LVMI cut-offs are also suitable for children over the age of
9 years, however, in younger patients LVMI is still height-
dependent. For children, normal values for LVM and LVMI
are available by Khoury [11], which for older children are
quite similar to the 95th percentile of LVMI found by the
group of de Simone [2, 12].
Several problems remain though: the ASE formula has not
been validated in children and because it uses squares of sev-
eral measurements, it is easily distorted by measurement er-
rors. Additionally, it is less suitable for patients with altered
geometry, which may sometimes be the case in fluid-
overloaded patients. Application of different echo reference
values can result in large differences in the number of children
classified to have LVH and thus raises doubt whether this
method is reliable in children with chronic kidney disease
[12, 13].
Cardiac magnetic resonance imaging (CMR) offers an al-
ternative for measuring LVM, which is not dependent on nor-
mal cardiac geometry, as heart contours are individually
traced. CMR has higher inter-reader and inter-study reproduc-
ibility for measuring LVM than echocardiography [14, 15].
Echo and CMR are both predictive of mortality but no head-
to-head comparison has been performed in any patient group
[16]. Two studies have employed CMR in children with CKD
and have been able to partially reproduce echocardiographic
findings [17, 18]. However, when compared to CMR, echo-
cardiography substantially overestimates LVM in adult hemo-
dialysis patients [19, 20], but this has not been examined in
children. Therefore, the aim of this study was to assess the
agreement of Echo and CMR in quantifying both left ventric-




Children and adolescents with chronic kidney disease stage 3
or higher (i.e., with an estimated glomerular filtration rate
(GFR) below 60 ml/min*1.73 m2) and/or who had undergone
renal transplantation were eligible for the study. The presence
of structural anomalies of the heart, cardiac valves or great
vessels, cardiomyopathies, a pacemaker, or other metallic
foreign bodies were exclusion criteria.
Imaging techniques
Cardiac magnetic resonance scans without contrast medium
were performed on a 1.5-Tesla scanner (TIM-Symphony,
Siemens, Erlangen, Germany). For the measurement of
LVM ECG-gated steady-state free precession (SSFP) cine im-
ages were taken of at least ten contiguous slices along the
short axis of the heart (parallel to the plane of the atrioventric-
ular valves) [21] using the following parameters: Echo time
1.25 ms, repetition time 3 ms, field of view 270 mm, slice
thickness 8 mm, temporal resolution 24.8 ms, spatial resolu-
tion 1.5–2 mm. End-diastolic epi- and endocardial contours of
the left ventricle were traced manually on each slice and a
software (Argus, Siemens) used to calculate the end-diastolic
left ventricular muscle volume (not including the papillary
muscles) by multiplication of the cross-sectional area by the
distance between slices. Further multiplication of the muscle
volume by the specific muscle weight yields ventricular mass
[22]. Stroke volume (SV) was measured as the difference
between the end-systolic and end-diastolic volume (ESV and
EDV), and the ejection fraction (EF) calculated as stroke
volume/end-diastolic volume.
On the same day, 2D-guided M-Mode echocardiography
was performed according to the standards of the American
Society of Echocardiography [23] by an experienced examin-
er on a Vivid 7 Dimension cardiovascular ultrasound system
(GE Healthcare, Milwaukee, WI, USA). Electronic calipers
were used to measure left ventricular end-diastolic diameter,
diastolic posterior wall thickness and interventricular septal
thickness in order to calculate left ventricular mass according
to the American Society of Echocardiography (ASE) formula
by Devereux [9]. EF was also calculated based on M-mode
measurements. For quality control, a number of examinations
were checked by a second examiner.
Clinical measurements
Clinical examination, anthropometric measurements, and
clinic blood pressure were usually taken on the same day as
the imaging procedures. The following blood parameters were
also measured: serum creatinine, cystatin C, bound urea nitro-
gen, standard blood count and electrolytes, parathyroid hor-
mone, 25-OH-vitamin D, N-terminal pro brain natriuretic pep-
tide (pro BNP), renin, and aldosterone (in supine position).
Spot urines were used to quantify proteinuria as total
protein/creatinine ratio. Ambulatory 24-h blood pressure mea-
surements (ABPM) were taken every 15 min during the day
and every 30 min during the night using Spacelabs 9,0207
monitors (Spacelabs Healthcare, Snoqualmie, WA, USA).
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Data on kidney function, blood pressure control, and med-
ication over 6 months preceding the study day were taken
from clinical records. From the time of study, serum creati-
nine, BUN, and body height were recorded prospectively until
start of renal replacement therapy (n=3) or transfer to adult
unit (n=8). Two patients were lost to follow-up and one ex-
cluded due to rapid loss of transplant function due to non-
compliance. The remaining 22 patients were followed up for
36.3±9.8 months (range, 12–49 months).
Normal values
For Echos, LVH was classified as LVMI>95th percentile for
age according to the largest available reference population
presented by Khoury et al. [11]. Incidentally, use of these
age- and height-dependent percentiles resulted in identical pa-
tients being classified as having LVH as the use of the age- and
height-independent cut-off found by the group of de Simone
[2, 12] (where LVMI above 38.6 g/m2.7 is considered hyper-
trophic). In addition, a relative wall thickness (RWT=posteri-
or wall thickness/left ventricular end diastolic diameter) great-
er than 0.375 was used to distinguish concentric from eccen-
tric hypertrophy and concentric remodeling from normal
cardiac structure [24].
For normal ranges of cardiac mass on CMR using SSFP,
normal populations have been examined by Buechel et al.
[25], Robbers-Visser et al. [26], as well as Sarikouch et al.
[27]. The latter two have been pooled by Kawel-Boehm [28]
and are used here, as they represent the largest cohort and use
an identical technique (e.g., papillary muscles not included in
volumes). We define LVH as LVM/BSA above the 95th per-
centile (mean+1.65 × standard deviation).
ABPM standard deviation scores of blood pressure were
calculated using normal values by Wühl et al. [29], while a
large up-to-date German reference study (KIGGS) was used
for normal values of clinic blood pressure and anthropometric
measurements [30, 31].
Statistics
Before the start of the study, a power analysis estimated that a
sample of about 15 children would be large enough to detect
significant differences of LVMI from the norm. Group com-
parisons were made using the Chi-square test for categorical
variables and Student’s t test for continuous variables. The
Bland–Altman method [32] was used to compare CMR and
Echo measurements. To compare classification of LVH,
Cohen’s kappa was used [33], where a value of 0 signifies
that the agreement between two methods is only as good as
chance and 1 that they agree perfectly (negative values are
possible and indicate agreement worse than expected by
chance). Values below 0.2 are generally regarded as poor
agreement and only above 0.61 as good or above 0.81 as very
good [34]. Correlations are quantified by giving Pearson’s
correlation coefficient. Throughout, p values less than 0.05
were considered significant. Statistical analyses were per-
formed using SAS V9.4 (SAS Institute, Cary, NC, USA).
Results
Patient characteristics
Twenty-eight patients consented to take part in the study. Two
patients (a 13-year-old female and a 17-year-old male) with-
drew due to unexpected claustrophobia in the scanner. One
CMR study was not analyzable due to data storage problems.
Of the remaining 25 children, 11 were males (44 %), 11 had
chronic kidney disease (44 %), and 14 had received a renal
transplant (56 %); none were on dialysis. Further patient char-
acteristics are shown in Table 1. CKD was due to renal
dysplasia or agenesis (with or without urinary tract
malformations) in nine patients, congenital or acquired glo-
merulopathy in nine, nephronophthisis in four, and other
causes in three patients. Small proteinuria (protein/creatinine
ratio 0.2–1 g/g in spot urine) was present in six patients and
large proteinuria (protein/creatinine ratio>1 g/g) in five chil-
dren, none of whom were nephrotic.
Mean blood pressure was mildly elevated (see Table 1),
however this was only possible with antihypertensive medi-
cation in 21 patients (85 %) (four patients received one agent,
ten received two agents, and seven received three or more
antihypertensive medications). The most commonly used
drugs were ACE inhibitors (n=14), amlodipine (n=13), met-
oprolol (n=11), angiotensin receptor blocker (n=6), and di-
uretics (n=3). Uncontrolled systolic hypertension was re-
vealed by ABPM in four patients, while none had diastolic
hypertension on ABPM. Three of these four had normal clinic
blood pressure, while seven children had white coat
hypertension.
Renal anemia was treated with iron supplements in eight
patients and with additional erythropoiesis-stimulating agents
in five. Overt anemia (hemoglobin below 11 g/l) was present
in five patients.
Echocardiography
Findings on standard echocardiography are shown in Table 2.
Left ventricular hypertrophy was present in eight children
(32 %), with exact agreement between the classification ac-
cording to normal values by Khoury [11] and Matteuci [2].
Hypertrophy was concentric in seven and eccentric in one
child (28 % and 4 %), while 12 of 17 without hypertrophy
had concentric remodeling (48 % overall). LVM for BSAwas
above the 95th percentile in seven children (of whom six also
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had an increased LVMI, but one was normal according to
Khoury [11]).
CMR
Left ventricular dimensions and functional parameters mea-
sured on CMR are shown in Table 3. CMR-LVM was
increased significantly (i.e., SDS significantly above 0, see
Table 3), while EDV, SV, and cardiac index were decreased
from normal. However, LV hypertrophy was present in
Table 1 Patient characteristics
Mean SD Minimum Maximum
Age (years) 13.72 2.85 8.3 17.7
Height (cm) 154.3 16.8 124 185
Weight (kg) 47.8 15.2 25.3 75.2
Body surface area* (m2) 1.43 0.3 0.96 1.92
Height SDS −0.79 1.02 −2.68 1.65
BMI SDS −0.19 0.8 −1.67 1.39
Systolic/diastolic BP (mmHg) 122/70 11/9 98/55 144/90
Systolic/diastolic BP SDS 0.97/0.57 0.9/1.2 −0.4/–1.3 3.1/3.35
Systolic/diastolic 24 h BP (mmHg) 116/68 8.1/5 101/56 129/76
Systolic/diastolic 24 h BP SDS 0.47/0.08 1.1/1.0 −0.9/–2.3 2.4/1.4
Creatinine (μmol/l) 151 95 69 473
Cystatin C (mg/l) 1.7 0.7 0.8 3.6
eGFR (creatinine**) (ml/min/1.73 m2) 62 26 14 113
eGFR (cystatin C***) (ml/min/1.73 m2) 60 24 21 116
Hemoglobin (g/dl) 12.4 1.6 8.4 14.4




***formula according to Filler [36]
Table 2 Echocardiographic measurements, left ventricular dimensions,
and systolic function in 25 children with chronic kidney disease and/or
after renal transplantation
Mean SD Minimum Maximum
Measurements of cardiac dimensions
LVEDD (mm) 41.6 5.0 33 51
LVPWT (mm) 8.92 2.06 6 15
IVST (mm) 8.72 2.30 5 13
Calculated cardiac dimensions
LVM (g) 117.0 39.7 62 207
LVMI (g/m2.7) 35.6 7.3 23 48
LVM/BSA (g/m2) 81.0 17.6 56 113
RWT 0.43 0.09 0.30 0.69
Parameters of systolic function
EF (%) 64.7 6.6 52 75
FS (%) 36.4 8.1 26 68
LVEDD left ventricular end diastolic diameter, LVPWT left ventricular
posterior wall thickness, IVST interventricular septal thickness, LVM left
ventricular mass, LVMI LVM index, RWT relative wall thickness, EF ejec-
tion fraction, FS endocardial fractional shortening, SD standard deviation
Table 3 Measurements and SDS scores of cardiac dimensions and
systolic function on cardiac magnetic resonance in 25 children with
chronic kidney disease and/or after renal transplantation
Mean SD Minimum Maximum p value
Measurements of cardiac dimensions
LVM (g) 88.7 29.0 47 154
LVMBSA (g/m
2) 61.1 10.6 43 84
LV EDV (ml) 103 31.9 50 181
LV ESV (ml) 38.7 16.4 16 85
Parameters of systolic function
EF (%) 63.3 8.4 39.8 75.2
SV (ml) 64.8 20.2 34.2 122.4
CI (l/min/m2) 3.32 0.9 1.69 5.33
SDS values according to Kawel-Boehm
LVM 0.39 0.8 −1.1 1.9 0.032
LVEDV −0.53 1.0 −2.5 1.6 0.015
LVESV −0.03 1.3 −2.0 3.7 ns
EF −0.25 1.6 −5.2 2.0 ns
SV −0.76 1.1 −3.1 1.4 0.002
CI −1.11 2.0 −3.6 1.0 0.001
LVM left ventricular mass, BSA body surface area, LVEDV left ventricular
end diastolic volume, LVESV left ventricular end systolic volume, EF
ejection fraction, CI cardiac index (cardiac output/BSA), SV stroke vol-
ume. SD standard deviation, SDS SD score
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only two children (8 %) according reference values
from Kawel-Boehm [28].
CMR-LVMI and CMR-LVMBSA were both correlated to
annualized GFR decline after the examination, i.e., future kid-
ney function (see Fig. 1, r=−0.52, p=0.01, and r=−0.49, p=
0.02). This was not true for Echo-LVMI or Echo-LVMBSA
(and only marginally for CMR-LVM SDS, r=−0.40, p=
0.06). CMR and Echo-LVM were not correlated to present
kidney function or to the slope of GFR decline prior to
examination.
Increased CMR-LVM SDS was negatively correlated to
aldosterone/renin ratio (r=−0.63, p=0.02), which was not true
for Echo-LVM-indices. Serum electrolytes, pH, PTH, vitamin D,
and various markers of anemia correlated neither with CMR-
nor Echo-LVM measures. Lean children had higher cardiac
output per BSA (cardiac index), with a correlation of CMR-CI
SDS to body mass index (BMI) SDS of r=−0.52 (p=0.007).
Agreement of left ventricular mass (LVM)
As is evident from Tables 2 and 3, absolute values of LVM
differed widely between the two groups with mean CMR-
LVM of 88.7±29.0 vs. mean echo-LVM of 117.0±39.7
(p<0.0001). Even though the correlation between both mea-
surements was high at r=0.91 (p<0.00), this is an imprecise
measure of agreement, and Fig. 2 shows that the regression
line is not parallel to the line of equivalence. The regression
equation was Echo-LVM=6.1+CMR-LVM* 1.25 with r2=
0.84 (p of slope<0.001, p of intercept 0.58).
The Bland–Altman plot (see Fig. 3) shows a mean differ-
ence between Echo- and CMR-LVM of 28.26±17.6 g. Thus,
the limits of agreement (mean±1.96 × SD) were −6.2 to
62.8 g. The visual impression of the Bland–Altman plot sug-
gests greater scatter at higher LVM measurements. This was
confirmed by a significant correlation of the LVM difference
to Echo-LVMI (r=0.77, p<0.0001) but not CMR-LVMI (r=
0.33, p=0.11). The LVMmeasurement difference did not cor-
relate to body dimensions, renal function, blood pressure, or
anemia nor did it differ between males and females, pre- and
post-transplantation or with stage of CKD.
However, the Echo-CMR difference of LVM was signifi-
cantly higher in eight children treated for anemia with iron
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Fig. 1 Correlation of prospective annualized loss of estimated
glomerular filtration rate (eGFR) with left ventricular mass (LVM)
normalized to body surface area (BSA) measured by cardiac magnetic
resonance (CMR). Solid line=regression line
40
40





Fig. 2 Correlation of left ventricular mass (LVM) on echocardiography
(Echo) and on cardiac magnetic resonance (CMR). Dotted line=line of
equivalence. Solid line=regression line
Fig. 3 Bland–Altman plot of the difference vs. the mean of left
ventricular mass (LVM) measured by echocardiography (Echo) and
cardiac magnetic resonance (CMR)
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vs. 22.6±14.5 g in 17 untreated patients, p=0.016) and corre-
lated to the dose of iron given (r=0.42, p=0.036). There was
no correlation to other markers of anemia such as hemoglobin,
erythrocyte count, or mean corpuscular volume.
Agreement of detecting left ventricular hypertrophy
(LVH)
The number of children with Echo-LVMI above the 95th per-
centile was much higher (n=8), than those with CMR-
LVMBSA above the 95th percentile (n=2) (see Table 4a).
Even though there was a stepwise increase of mean CMR-
LVM SDS from those with normal echocardiography (n=5,
0.03±0.8), to concentric remodeling (n=12, 0.33±0.86), to
concentric hypertrophy (n=7, 0.64±0.94) and to eccentric hy-
pertrophy (n=1, 1.13), this did not reach statistical signifi-
cance on ANOVA testing. Also, one of the two patients with
CMR-LVH had a normal echocardiogram, however this pa-
tient’s CMR-LVMBSA was only on the 96th percentile (SDS
1.76). Thus, the agreement between the two methods was only
poor with a Cohen’s kappa of 0.08 (95 % CL −0.23 to 0.40).
Presuming CMR to be the gold standard, echo had a poor
specificity of 69.6 % (CI 47–87 %) and poor sensitivity of
50 % (95 % CI 1.3–98.7 %). Only the negative predictive
value was good with 94.12 % (95 % CI 71.3–99.9 %), while
the positive predictive value was expectedly low at 12.5 %
(95 % CI 0.3–52.7 %).
To assess whether this disagreement was only due to the
different indexing methods that are routinely used for Echo-
LVM (to height to the power of 2.7) and CMR-LVM (to
BSA), we calculated the incidence of Echo-LVH defined as
Echo-LVMBSA above the 95th percentile (see Table 4b).
However, this only resulted in marginal improvement, with
one less patient having Echo-LVH, resulting in a slightly bet-
ter, but still poor Cohen’s kappa of 0.11 (95 % CI −0.24 to
0.46). Accordingly, there was a slight increase of specificity
(73.9 %) and positive predictive value (14.3 %), with identical
sensitivity and negative predictive value.
Figure 4 shows the individual differences between Echo-
LVMI percentile groups and CMR-LVMBSA SDS score. Even
though the Echo-LVMI percentiles were higher generally
speaking, this was by no means true for all patients and there
was considerable scatter.
Agreement of ejection fraction (EF)
Even though mean ejection fraction measured by echocardi-
ography and CMR was similar (64.7±6.6 vs. 63.3±8, p=ns),
correlation was worse than for LVM (r=0.57, p=0.003,
see Fig. 5). The regression equation was Echo-EF=
36.3+CMR-EF * 0.45 (p=0.0003 for intercept. p=
0.003 for slope). The Bland–Altman plot shows a mean
difference of 1.42 percentage points (limits of agree-
ment: −12.6 to 15.4), with greater scatter at ejection
fractions below 60 % (see Fig. 6).
Thus, the agreement of detecting a reduced ejection
fraction (below 55 %) was poor with a Cohen’s kappa
of 0.17 (95 % CI −0.31–0.65); see Table 5. Assuming
CMR to be the gold standard, echo had a good speci-
ficity of 90.5 % and negative predictive value of
86.4 %, but a very poor sensitivity of 25 % and posi-
tive predictive value of only 33 %.
As for LVM, the Echo-CMR difference of EF was signif-
icantly higher in children treated for anemia (ΔEF 5.71±
6.8 % vs. −0.61±6.5 %, p=0.036) and correlated to the dose
of iron given (r=0.61, p=0.0013), but not to other markers of
anemia.
Table 4 Agreement of left ventricular hypertrophy (LVH) found on
cardiac magnetic resonance (CMR) and echocardiography (Echo)
CMR-LVMBSA
>95th percentile Normal Total
(a) Using standard indexing methods
Echo-LVMI >95th percentile 1 7 8
Normal 1 16 17
Total 2 23 25
(b) Using indexing to body surface area (BSA) for both methods
Echo-LVMBSA >95th percentile 1 6 7
Normal 1 17 18
Total 2 23 25
LVMI left ventricular mass index
Fig. 4 Agreement of echocardiographic left ventricular mass index
(Echo-LVMI) percentiles according to Khoury [11] with CMR-LVMBSA
standard deviation score (SDS) according to Kawel-Boehm [28].
CMR cardiac magnetic resonance, LVM left ventricular mass
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Comparison of patients pre- and post-kidney transplant
(KTx)
Patients with KTx had higher estimated GFR than those with-
out (74±23 vs. 47±21 ml/min*1.73 m2, p=0.005), but the
two groups did not differ significantly with respect to age,
gender, anthropometric measurements, anemia, ambulatory
blood pressure or frequency, and intensity of antihypertensive
treatment. The Echo-MRI differences in LVM, nLVM, and EF
tended to be larger in patients with KTx, but these differences
were not significant. Cohen’s kappa for agreement of LVH
classification was also worse in the KTx group, but 95 %
confidence intervals overlap widely (0.12 (−0.37 to 0.1) vs.
0.42 (−0.17 to 1)).
Discussion
With the improving prognosis of children with chronic kidney
disease, increasing numbers of survivors are affected by se-
vere cardiovascular disease starting in early adulthood [37];
thus, measuring left ventricular mass as a surrogate marker of
cardiovascular disease is becoming clinically increasingly rel-
evant in trying to prevent these changes. Echocardiography
has been the standard technique for many years, but cardiac
magnetic resonance offers an alternative which is promising,
especially with regard to reliably measuring left ventricular
volume independent of geometric assumptions, which may
not hold for volume overloaded patients. Echo has been
shown to overestimate CMR-LVM in adults with reduced
renal function [19, 20] and hypertension [38, 39], but evidence
is less clear in children [40].While CMR is generally accepted
as superior in quantifying LVM, the lack of validation with
autopsy studies means it is not yet a solid gold standard. The
aim of this study was to compare how well Echo and CMR
agree in children with CKD and whether one method showed
better correlation to renal parameters than the other.
On echocardiography, we find an incidence of left ventric-
ular hypertrophy of 32%, which is similar to previous studies,
but with a higher proportion of concentric vs. eccentric chang-
es compared to previous reports [1, 2, 41, 42]. However, adult
CMR studies have suggested that dialysis patients have a
unique kind of LVH, which is neither clearly concentric nor
eccentric [43], which may be the cause of varying classifica-
tion. The incidence of LVH was much lower on CMR with
only 8 %. However, CMR-LVM SDS was still significantly
increased from normal, confirming early cardiac changes
found in previous studies [17, 18]. Importantly, CMR-LVM
and CMR-LVMBSA were able to predict GFR decline, which
has not been found in any other pediatric echocardiographic
studies. This relationship is plausible, as it has also been de-
scribed in adult CKD patients [44]. As part of the cardiorenal
syndrome, a small but significant influence of LVM on renal
Fig. 5 Correlation of ejection fraction (EF) on echocardiography (Echo)
and on cardiac magnetic resonance (CMR). Dotted line=line of
equivalence. Solid line=regression line
Fig. 6 Bland–Altman plot of the difference vs. the mean of ejection
fraction (EF) measured by echocardiography (Echo) and cardiac
magnetic resonance (CMR)
Table 5 Measurement of ejection fraction (EF) with echocardiography
(Echo-) and cardiac magnetic resonance (CMR)
CMR-EF
<55 % >55 % Total
Echo-EF <55 % 1 2 3
>55 % 3 19 22
Total 4 21 25
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outcome is also found in studies in adult hypertensives
[45, 46].
The comparison of LVMmeasurements by Echo and CMR
showed a systematic difference between the two methods,
where Echo-LVM was markedly higher than CMR-LVM,
with an increasing difference at higher mean LVMs (see
Figs. 2 and 3). As the difference did not correlate to body
dimensions or CMR-LVM, but only to Echo-LVM, it can be
postulated that it is due to a systematic error of the echo for-
mula. Other authors have also found Echo-LVM to overesti-
mate CMR-LVM, especially with reduced renal function [19,
20]. Indeed, the correlation of Echo-CMR-LVM difference to
mean LVM found by Jakubovic et al. appears very sim-
ilar to that in our study [20]. Absolute Echo-LVM dif-
ferences only appear smaller in our study due to the
smaller heart sizes in children. We also find that Echo-
CMR agreement of both LVM and EF was worse for
patients treated for anemia, which may also relate to
larger intravascular volume and consequently altered
ventricular geometry in this group. To resolve this dis-
crepancy, necropsy validated studies of CMR and Echo
in patients with distorted geometry would be desirable.
On the other hand, comparing absolute LVM may jus-
tifiably be criticized as comparing Bapples with oranges^
as differences are inconsequential if application of correct
reference values yields comparable results. We therefore
also compared the classification of left ventricular hyper-
trophy using accepted standards (95th percentile cut-offs
of LVMI for echo and LVMBSA for CMR), which still
resulted in only poor agreement between the two methods
with Cohen’s kappa indicating agreement not significantly
better than expected by chance. Applying identical
indexing methods (i.e., 95th percentile of LVMBSA for
both methods) this could only be marginally improved
(see Table 4a and b). Indexing LVM to BSA seems to
underestimate the prevalence of hypertrophy especially
in overweight patients [47], but while indexing to height
2.7 is more predictive of mortality in adult hemodialysis
patients than indexing to BSA [48], it is still a matter of
debate which method is superior in the general population
[49, 50]. In addition to the ongoing debate about the best
way to index LVM [51], this matter is complicated further
by the pediatric need for age-adjusted reference values
(see supplementary table for an overview of available
normal values). It is therefore unsurprising that the
Echo-CMR agreement of assigning LVH is even poorer
in our children than in adult CKD and hypertensive cohorts
[20, 52].
With regard to cardiac function, CMR revealed a sig-
nificant reduction of stroke volume, cardiac index, and
end-diastolic volume in our cohort of CKD children,
while ejection fraction was preserved. In a similar popu-
lation a previous CMR study also found normal EF. [18]
Other functional cardiac studies on CKD children have
employed various Echo techniques finding reduced frac-
tional shortening and reduced EF, but both increased or
decreased contractility [1, 3, 42, 53]. However, our com-
parison of Echo- and CMR-EF shows that agreement
between both methods is far from optimal and especially
poor in the clinically most relevant spectrum of EF be-
low 60 % (see Figs. 5 and 6), even though it was slightly
better than in children with aortic insufficiency [54].
Thus there was only a poor Cohen’s kappa of 0.17 for
detecting reduced EF below 55 %. Measurement of other
functional indices on Echo, such as cardiac output is
difficult, as the estimation of stroke volume requires the
velocity time integral of flow at left ventricular outflow
tract. One functional study employing Echo and exercise
testing found increased CO and SV in children with
CKD and LVH compared to those with CKD without
LVH, however there was no comparison to normal chil-
dren [55]. We too find a positive correlation of CMR-
LVMBSA to SVBSA (r=0.44, p=0.03), but not to CO,
however the overall SV and CO are decreased.
A CMR study in adult dialysis patients found de-
creased EF and increased EDV in adult dialysis patients,
while EF was normal and EDV decreased in our pedi-
atric non-dialysis population, which probably reflects
more advanced stages of uremic cardiomyopathy in
adults together with larger volume fluctuations under
hemodialysis [43]. Other Echo studies in pediatric
CKD have also found predominantly diastolic changes
[56, 57], suggesting that impaired diastolic relaxation
precedes systolic changes in uremic cardiomyopathy.
The current evidence does not justify the degradation
of echocardiography, as it remains not only much easier
and cheaper in clinical practice but also has the larger
evidence base for outcome data so far. New develop-
ments such as 3D echocardiography show better corre-
lation of LVM to CMR than 2D Echo even in children
and may be suitable alternatives for clinical trials
[58–60]. On the other hand, CMR is becoming increas-
ingly available, protocols to measure LVM are relatively
short (<30 min) and do not require contrast medium and
mass calculations are reproducible and less laborious
with semi-automated tracing of ventricular outlines.
In summary, we find that Echo significantly overes-
timates LVM compared to CMR in children with CKD,
which is consistent with previous findings from adults.
The discrepancy between both methods is not easily
removed by application of reference values, partly be-
cause a number of different reference populations and
methods of indexing exist. The fact that CMR-LVM
shows better prediction of GFR decline here suggests
that it is worth further investigating the prognostic value
of CMR vs. echocardiography.
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Glossary
BSA Body surface area




LVM Left ventricular mass
LVH Left ventricular hypertrophy
LVMI LVM indexed to height in m2.7
LVMBSA LVM normalized to body surface area
ABPM 24-hour ambulatory blood pressure measurement
CKD Chronic kidney disease
CI Confidence interval
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